These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 20090554

  • 1. Treatment with angiotensin receptor blockers before stroke could exert a favourable effect in acute cerebral infarction.
    Fuentes B, Fernández-Domínguez J, Ortega-Casarrubios MA, SanJosé B, Martínez-Sánchez P, Díez-Tejedor E.
    J Hypertens; 2010 Mar; 28(3):575-81. PubMed ID: 20090554
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin 2 type 2 receptor activity and ischemic stroke severity.
    Ovbiagele B, Kidwell CS, Starkman S, Selco SL, Rajajee V, Razinia T, Saver JL.
    Neurology; 2005 Sep 27; 65(6):851-4. PubMed ID: 16186522
    [Abstract] [Full Text] [Related]

  • 3. Benefits of prestroke use of angiotensin type 1 receptor blockers on ischemic stroke severity.
    Miyamoto N, Tanaka Y, Ueno Y, Tanaka R, Hattori N, Urabe T.
    J Stroke Cerebrovasc Dis; 2012 Jul 27; 21(5):363-8. PubMed ID: 21094055
    [Abstract] [Full Text] [Related]

  • 4. Blood pressure and antihypertensive therapy as predictors of early outcome in acute ischemic stroke.
    Keezer MR, Yu AY, Zhu B, Wolfson C, Côté R.
    Cerebrovasc Dis; 2008 Jul 27; 25(3):202-8. PubMed ID: 18212508
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin converting enzyme inhibitor and angiotensin receptor blockade use in relation to outcomes in anticoagulated patients with atrial fibrillation.
    Lip GY, Frison L, Grind M.
    J Intern Med; 2007 Jun 27; 261(6):577-86. PubMed ID: 17547713
    [Abstract] [Full Text] [Related]

  • 6. Is prestroke use of angiotensin-converting enzyme inhibitors associated with better outcome?
    Chitravas N, Dewey HM, Nicol MB, Harding DL, Pearce DC, Thrift AG.
    Neurology; 2007 May 15; 68(20):1687-93. PubMed ID: 17502550
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep 15; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of applied cases of thrombolytic therapy against ultra-acute ischemic stroke. Using the Japanese Standard Stroke Registry Database.
    Shiotsuki H, Ogushi Y, Fushimi K, Kobayashi S, Japanese Standard Stroke Registry Study (JSSRS) Group.
    Tokai J Exp Clin Med; 2005 Apr 15; 30(1):49-62. PubMed ID: 15952299
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Cerebrovascular sequelae of hypertension].
    Schrader J, Lüders S, Diener HC.
    Herz; 2003 Dec 15; 28(8):707-16. PubMed ID: 14689105
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pre-stroke use of antihypertensives, antiplatelets, or statins and early ischemic stroke outcomes.
    Yu AY, Keezer MR, Zhu B, Wolfson C, Côté R.
    Cerebrovasc Dis; 2009 Dec 15; 27(4):398-402. PubMed ID: 19276623
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA.
    J Hum Hypertens; 2003 Apr 15; 17(4):277-85. PubMed ID: 12714973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.